Herantis (public company)
See something wrong or missing? Let us know
Offices:Helsinki, Turku
Industry:Pharma
Business model:B2B
Herantis Pharma Plc is an innovative drug development company focused on regenerative medicine and unmet clinical needs.
Our first-in-class assets are based on globally leading scientific research in their fields: CDNF for disease modification in neurodegenerative diseases, primarily Parkinson’s and ALS; and Lymfactin® for breast cancer associated lymphedema, with potential also in other lymphedemas.
The shares of Herantis are listed on the First North Finland marketplace run by Nasdaq Helsinki stock exchange.
values in USD
No transactions tracked yet
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Companies with similar profile to Herantis
| Name | Criteria | |
|---|---|---|
 |
1000Farmacie
23%
|
|
 |
3Z Pharmaceuticals
23%
|
|
 |
ABC Transfer
23%
|
|
 |
Ability Pharma
23%
|
|
|
AbolerIS Pharma
23%
|
|
|
Accure Therapeutics
23%
|
|
 |
AFYX Therapeutics
23%
|
|
 |
Aignostics
23%
|
|
|
Algo Therapeutix
23%
|
|
|
Amadix
23%
|
|
Belgium
Netherlands
Austria
Switzerland
Estonia
Latvia
Lithuania
Norway
Sweden
Ireland
Portugal
United Kingdom